Home » ULURU INC. PURCHASES TOPICAL ASSETS OF ACCESS PHARMACEUTICALS INC.
ULURU INC. PURCHASES TOPICAL ASSETS OF ACCESS PHARMACEUTICALS INC.
ULURU Inc., a private company established to develop a portfolio of advanced
topical delivery technologies, today announced that it has purchased the topical
product assets of Access Pharmaceuticals, Inc. (AMEX: AKC). Additionally, ULURU
Inc. signed a definitive merger agreement with Oxford Ventures, Inc. ("Oxford").
Under the terms of the merger agreement ULURU Inc. will become a wholly owned
subsidiary of Oxford on the terms previously disclosed by Oxford in a Form 8-K
filling with the Securities and Exchange Commission on September 13, 2005.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May